Innovations in adaptive clinical trial designs have unlocked new possibilities for more efficient, cost-effective, and ethical clinical trials. But as more methods are introduced, biostatisticians struggle to optimize the growing number of interdependent trial parameters and ensure control over various execution assumptions. This is especially true for multi-arm multi-stage (MAMS) trial designs.

The solution? The Explore tool in Cytel’s East Horizon™ platform, which uses a combination of cloud computing and design-selection algorithms, enables trial optimization and parameter selection in a systematic and holistic way. In a quickly evolving and competitive landscape where uncertainties surround a treatment’s true underlying effect or the standard of care at launch, the pivotal role of cloud-based simulation and optimization becomes evident to ensure overall program success.

Download our white paper to discover how Cytel’s East Horizon Explore can help you transform your clinical development approach and propel your journey toward success.